Elizabeth E Roughead
Biographic Data
| ID | 1725030 |
|---|---|
| NAME | Elizabeth E Roughead |
| GIVEN NAMES | Elizabeth E |
| FAMILY NAME | Roughead |
| SIGNATURE | ROUGHEAD E E |
| AFFILIATIONS | University of South Australia |
| ORCID | 0000-0002-6811-8991 |
| VERIFIED | Yes |
| TOTAL WORKS | 9 |
| TOTAL CITATIONS | 3 |
| WORKS AS AUTHOR | 9 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 1999 |
| LATEST PUBLICATION YEAR | 2020 |
| H-INDEX | 1 |
Use of analgesics following rescheduling of codeine in Australia
Inflated medicine prices in Vietnam
One third of the world's population lacks regular access to essential medicines partly because of the high cost of medicines. In Vietnam, the cost to patients of medicines was 47 times the international reference price for originator brands and 11 times the price for generic equivalents in the public sector. In this article, we report the results of a qualitative study conducted to identify the principal reasons for inflated medicine prices in Vi…
Commitment questions targeting patients promotes uptake of under-used health services
Medicines information provided by pharmaceutical representatives
Information on indications and dosages were usually provided by pharmaceutical representatives in Australia and Malaysia. However, risk and harmful effects of medicines were often missing in their presentations. Effective control of medicines information provided by pharmaceutical representatives is needed
Comorbid chronic diseases, discordant impact on mortality in older people
OBJECTIVES: To determine the impact of comorbid chronic diseases on mortality in older people. DESIGN: Prospective cohort study (1992-2006). Associations between numbers of chronic diseases or mutually exclusive comorbid chronic diseases on mortality over 14 years, by Cox proportional hazards model adjusting for sociodemographic variables or Kaplan-Meier analyses, respectively. SETTING: Population based, Australia. PARTICIPANTS: 2087 randomly sel…
Medicaid Prior Authorization and Controlled-Release Oxycodone
BACKGROUND: Since its introduction in 1996, controlled-release (CR) oxycodone use has increased steadily despite its high cost. To control use and expenditures, many Medicaid programs have implemented CR oxycodone prior authorization (PA) policies. Few studies evaluate Medicaid policies or compare lenient and strict policies in multiple states. OBJECTIVE: To estimate the impact of PA on CR oxycodone use by Medicaid beneficiaries. DESIGN: Secondar…
Trends and Geographic Variation of Opiate Medication Use in State Medicaid Fee-For-Service Programs, 1996 to 2002
BACKGROUND: Although studies have documented hospital and surgical service geographic variability, prescription use geographic variability is largely unknown. Opiate pain medications are widely used, particularly because the promulgation of clinical guidelines promoting aggressive pain treatment. This study describes temporal and interstate variability in aggregate prescription opiate medication use within U.S. Medicaid programs. METHODS: A datas…
Differential Effect of Early or Late Implementation of Prior Authorization Policies on the Use of Cox II Inhibitors
BACKGROUND: State Medicaid programs introduce many types of prescribing restrictions to manage pharmaceutical use and expenditure. Little is known about the differential effect of implementing prior authorization (PA) policies at market entry versus waiting until several years later when prescribing behavior may already be established. OBJECTIVES: We sought to examine the impact on overall use of Cox II inhibitors of PA policies implemented at ma…
Improving drug use
Comorbid chronic diseases, discordant impact on mortality in older people
OBJECTIVES: To determine the impact of comorbid chronic diseases on mortality in older people. DESIGN: Prospective cohort study (1992-2006). Associations between numbers of chronic diseases or mutually exclusive comorbid chronic diseases on mortality over 14 years, by Cox proportional hazards model adjusting for sociodemographic variables or Kaplan-Meier analyses, respectively. SETTING: Population based, Australia. PARTICIPANTS: 2087 randomly sel…
Improving drug use
Improving drug use
Trends and Geographic Variation of Opiate Medication Use in State Medicaid Fee-For-Service Programs, 1996 to 2002
BACKGROUND: Although studies have documented hospital and surgical service geographic variability, prescription use geographic variability is largely unknown. Opiate pain medications are widely used, particularly because the promulgation of clinical guidelines promoting aggressive pain treatment. This study describes temporal and interstate variability in aggregate prescription opiate medication use within U.S. Medicaid programs. METHODS: A datas…
Differential Effect of Early or Late Implementation of Prior Authorization Policies on the Use of Cox II Inhibitors
BACKGROUND: State Medicaid programs introduce many types of prescribing restrictions to manage pharmaceutical use and expenditure. Little is known about the differential effect of implementing prior authorization (PA) policies at market entry versus waiting until several years later when prescribing behavior may already be established. OBJECTIVES: We sought to examine the impact on overall use of Cox II inhibitors of PA policies implemented at ma…
Medicaid Prior Authorization and Controlled-Release Oxycodone
BACKGROUND: Since its introduction in 1996, controlled-release (CR) oxycodone use has increased steadily despite its high cost. To control use and expenditures, many Medicaid programs have implemented CR oxycodone prior authorization (PA) policies. Few studies evaluate Medicaid policies or compare lenient and strict policies in multiple states. OBJECTIVE: To estimate the impact of PA on CR oxycodone use by Medicaid beneficiaries. DESIGN: Secondar…
Medicines information provided by pharmaceutical representatives
Information on indications and dosages were usually provided by pharmaceutical representatives in Australia and Malaysia. However, risk and harmful effects of medicines were often missing in their presentations. Effective control of medicines information provided by pharmaceutical representatives is needed
Comorbid chronic diseases, discordant impact on mortality in older people
OBJECTIVES: To determine the impact of comorbid chronic diseases on mortality in older people. DESIGN: Prospective cohort study (1992-2006). Associations between numbers of chronic diseases or mutually exclusive comorbid chronic diseases on mortality over 14 years, by Cox proportional hazards model adjusting for sociodemographic variables or Kaplan-Meier analyses, respectively. SETTING: Population based, Australia. PARTICIPANTS: 2087 randomly sel…
Commitment questions targeting patients promotes uptake of under-used health services
Inflated medicine prices in Vietnam
One third of the world's population lacks regular access to essential medicines partly because of the high cost of medicines. In Vietnam, the cost to patients of medicines was 47 times the international reference price for originator brands and 11 times the price for generic equivalents in the public sector. In this article, we report the results of a qualitative study conducted to identify the principal reasons for inflated medicine prices in Vi…
Use of analgesics following rescheduling of codeine in Australia
Medicine (9 works) · Environmental health (5 works) · Internal Medicine (5 works) · Population (5 works) · Internal Medicine (4 works) · Business (3 works) · Health care (3 works) · Medicaid (3 works) · Nursing (3 works) · Opioid Use Disorder Treatment (3 works)